LC216 is the high-content 216mg lipolytic formulation for extended and larger-scale adipose tissue research protocols. Same active profile as LC120 with increased content per unit.
LC216 is the high-content version of the LC lipolytic research formulation series, providing 216mg of active components per unit. This increased content is designed for extended research protocols, larger-scale in vitro studies, and dose-escalation experiments investigating adipocyte membrane dynamics, lipolysis pathway activation, and lipid clearance mechanisms. LC216 shares the same active ingredient profile and quality specifications as LC120, differing only in content per unit for experimental flexibility.
Research applications include multi-dose adipocyte biology studies, dose-response curve generation, comparative lipolysis research, and extended time-course experiments requiring sustained or repeated application.
Supplied as a ready-to-use solution. Store at 2-8°C protected from light. For adipocyte biology and metabolic research only.